Eli Lilly’s revenue rises about 48% as strong demand for its GLP-1 therapies lifts sales, according to reports from MarketWatch and Global News (Canada). Both outlets attribute the growth to higher-than-expected consumer and clinical demand for Mounjaro and Zepbound, Lilly’s GLP-1 medicines used to treat Type 2 diabetes and support weight loss. Global News (Canada) reports that Mounjaro sales grow 91% in the second quarter to about US$9.94 billion, exceeding analysts’ expectations. MarketWatch similarly points to demand for Lilly’s GLP-1 drugs as the primary driver of the company’s revenue increase. Together, the articles indicate that Lilly is benefiting from continued market demand for GLP-1 products, with quarterly results coming in above what analysts projected. The reporting also frames these results within broader GLP-1 market competition, noting that Novo Nordisk is another major producer of similar therapies, though the figures cited focus on Lilly’s performance.
Eli Lilly sales surge on strong demand for GLP-1 drugs Mounjaro and Zepbound
Eli Lilly’s revenue rises about 48% as strong demand for its GLP-1 therapies lifts sales, according to reports from MarketWatch and Global News (Canada). Both outlets attribute the growth to higher-th...
- Eli Lilly reports a revenue increase of about 48% driven by GLP-1 drug demand.
- Mounjaro sales rise sharply in the second quarter, increasing 91% to about US$9.94 billion.
- The reported Mounjaro results exceed analysts’ expectations.
- Zepbound and Mounjaro are cited as key contributors, with uses spanning Type 2 diabetes and weight loss.
- The coverage references the broader GLP-1 market, including Novo Nordisk, but the cited sales figures focus on Lilly.
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
3 hours agoIts sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
11 hours ago
US moves to shut Kentucky organ donation group over alleged patient safety failures
The US federal government moves to shut down an organ donation group in Kentucky, according to multiple outlets. The adm...
Man jailed for raping woman in caravan after Royal Windsor Horse Show
A man is sentenced to more than eight years in prison after raping a woman who was asleep in her caravan following the R...
Ravens agree to four-year, $140 million extension with wide receiver Zay Flowers
The Baltimore Ravens agree to a four-year contract extension with wide receiver Zay Flowers, a deal reported at $140 mil...